HC Wainwright & Co. Reiterates Buy on Stoke Therapeutics, Maintains $35 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $35 price target.
EF Hutton Reiterates Buy on Amprius Technologies, Maintains $14 Price Target
EF Hutton analyst Chip Moore reiterates Amprius Technologies (NYSE:AMPX) with a Buy and maintains $14 price target.
Qualtrics Could Bag A Higher Takeover Premium, Analyst Says Post Offer From Silver Lake & Canada Pension Plan
Piper Sandler analyst Brent Bracelin maintains Qualtrics International Inc (NASDAQ:XM) with an Overweight, raising the price target from $16 to $18.15. On…
Needham Reiterates Buy on Riot Platforms, Maintains $9 Price Target
Needham analyst John Todaro reiterates Riot Platforms (NASDAQ:RIOT) with a Buy and maintains $9 price target.
Needham Reiterates Buy on Ciena, Maintains $70 Price Target
Needham analyst Alex Henderson reiterates Ciena (NYSE:CIEN) with a Buy and maintains $70 price target.
Needham Reiterates Buy on SEMrush Hldgs, Maintains $20 Price Target
Needham analyst Scott Berg reiterates SEMrush Hldgs (NYSE:SEMR) with a Buy and maintains $20 price target.
Needham Reiterates Buy on RxSight, Maintains $22 Price Target
Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.
Telsey Advisory Group Reiterates Outperform on Lulus Fashion Lounge, Maintains $9 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Lulus Fashion Lounge (NASDAQ:LVLU) with a Outperform and maintains $9 price target.
Needham Reiterates Buy on Stoke Therapeutics, Maintains $25 Price Target
Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $25 price target.
Piper Sandler Reiterates Neutral on Olo, Maintains $9 Price Target
Piper Sandler analyst Clarke Jeffries reiterates Olo (NYSE:OLO) with a Neutral and maintains $9 price target.